PubRank

Timothy M Johnson

Author PubWeight™ 122.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Efficient tumour formation by single human melanoma cells. Nature 2008 16.35
2 Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010 4.81
3 Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010 3.70
4 Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010 2.83
5 Melanoma information on the Internet: often incomplete--a public health opportunity? J Clin Oncol 2002 2.61
6 Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006 2.58
7 Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 2004 2.42
8 Electrosurgery and implantable electronic devices: review and implications for office-based procedures. Dermatol Surg 2011 2.07
9 BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006 1.85
10 Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol 2004 1.85
11 The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 2009 1.85
12 Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007 1.83
13 Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011 1.75
14 Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 2005 1.68
15 The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer 2007 1.64
16 Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004 1.58
17 Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 2004 1.50
18 Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA 2004 1.49
19 Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 2009 1.39
20 Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. J Am Acad Dermatol 2006 1.38
21 Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma. Oncotarget 2012 1.36
22 Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol 2010 1.35
23 Human melanoma metastasis in NSG mice correlates with clinical outcome in patients. Sci Transl Med 2012 1.18
24 Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011 1.16
25 Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older. Ann Surg Oncol 2015 1.15
26 Distinct gene expression profiles of viral- and nonviral-associated merkel cell carcinoma revealed by transcriptome analysis. J Invest Dermatol 2012 1.14
27 Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer 2011 1.14
28 Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev 2009 1.12
29 Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin. Am J Pathol 2007 1.11
30 Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol 2004 1.08
31 A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol 2011 1.06
32 An education theory-based method to teach a procedural skill. Arch Dermatol 2004 1.04
33 Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol 2009 1.04
34 Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients. Cancer 2003 1.03
35 Thin primary cutaneous melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 2002 1.02
36 Getting patients to the right healthcare sources: from real-world questions to strategy hubs. Proc AMIA Symp 2002 1.01
37 EGF gene polymorphism and the risk of incident primary melanoma. Cancer Res 2004 1.01
38 Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. J Invest Dermatol 2013 1.00
39 Wide excision without radiation for desmoplastic melanoma. Cancer 2005 1.00
40 Dermal matrix remodeling after nonablative laser therapy. J Am Acad Dermatol 2005 0.96
41 BRAF and NRAS mutations in spitzoid melanocytic lesions. Mod Pathol 2006 0.95
42 Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 2011 0.95
43 Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 2009 0.94
44 Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control 2005 0.94
45 Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol 2011 0.94
46 Gender differences in melanoma awareness and detection practices between middle-aged and older men with melanoma and their female spouses. Arch Dermatol 2009 0.93
47 Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009 0.92
48 Dermatoscopic vascular patterns in cutaneous Merkel cell carcinoma. J Am Acad Dermatol 2011 0.92
49 Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 2005 0.91
50 Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J Am Acad Dermatol 2005 0.91
51 Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients. Ann Surg Oncol 2014 0.91
52 Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 2013 0.90
53 Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2006 0.90
54 Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol 2005 0.89
55 Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 2011 0.88
56 Is a level III dissection necessary for a positive sentinel lymph node in melanoma? J Surg Oncol 2011 0.87
57 Copy number variations and clinical outcome in atypical spitz tumors. Am J Surg Pathol 2011 0.87
58 Standard immunostains for melanoma in sentinel lymph node specimens: which ones are most useful? J Am Acad Dermatol 2004 0.86
59 Internet use and anxiety in people with melanoma and nonmelanoma skin cancer. Dermatol Surg 2011 0.85
60 Introduction to flap movement: reconstruction of five similar nasal defects using different flaps. Dermatol Surg 2005 0.85
61 Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. Radiother Oncol 2008 0.85
62 Microdermabrasion with and without aluminum oxide crystal abrasion: a comparative molecular analysis of dermal remodeling. J Am Acad Dermatol 2006 0.84
63 Desmoplastic and neurotropic melanoma. Cancer 2004 0.84
64 Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg 2013 0.83
65 Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002 0.83
66 Melanoma. J Natl Compr Canc Netw 2006 0.83
67 Molecular effects of photodynamic therapy for photoaging. Arch Dermatol 2008 0.82
68 Vascular expression of matrix metalloproteinase-13 (collagenase-3) in basal cell carcinoma. Exp Mol Pathol 2003 0.82
69 Reliability of sentinel lymph node biopsy for regional staging of head and neck Merkel cell carcinoma. Arch Otolaryngol Head Neck Surg 2005 0.81
70 Nonsteroidal anti-inflammatory drugs and risk of melanoma. J Skin Cancer 2011 0.81
71 Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma. J Am Acad Dermatol 2004 0.81
72 Tretinoin treatment before carbon-dioxide laser resurfacing: a clinical and biochemical analysis. J Am Acad Dermatol 2004 0.81
73 Current management of patients with melanoma who are pregnant, want to get pregnant, or do not want to get pregnant. Cancer 2003 0.81
74 Examining the pathways linking lower socioeconomic status and advanced melanoma. Cancer 2011 0.80
75 A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris. J Am Acad Dermatol 2007 0.80
76 Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease. J Am Acad Dermatol 2013 0.80
77 Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit. J Invest Dermatol 2011 0.79
78 Placental metastasis of maternal melanoma. J Am Acad Dermatol 2003 0.79
79 Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol 2008 0.79
80 Vulvar melanoma: review of diagnosis, staging, and therapy. J Low Genit Tract Dis 2004 0.78
81 Effect of carbon dioxide laser resurfacing on epidermal p53 immunostaining in photodamaged skin. Arch Dermatol 2004 0.78
82 Melanoma: do we need a hatchet or a scalpel? Arch Dermatol 2009 0.77
83 Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma. Nat Commun 2016 0.77
84 Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases. Clin Exp Pharmacol Physiol 2009 0.77
85 Vulvar melanoma in a 10-year-old girl in association with lichen sclerosus. J Am Acad Dermatol 2006 0.77
86 Forehead donor site full-thickness skin graft. Dermatol Surg 2005 0.77
87 Merkel cell carcinoma. J Natl Compr Canc Netw 2006 0.76
88 Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2003 0.76
89 Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease. J Am Acad Dermatol 2013 0.76
90 Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol 2014 0.76
91 The management of head and neck melanoma. Curr Probl Surg 2006 0.76
92 Immediate, optimal reconstruction of facial lentigo maligna and melanoma following total peripheral margin control. Plast Reconstr Surg 2007 0.76
93 The role of full-thickness scalp resection for management of primary scalp melanoma. Ann Plast Surg 2012 0.76
94 The effects of laser-mediated hair removal on immunohistochemical staining properties of hair follicles. J Am Acad Dermatol 2006 0.76
95 Antibiotic prophylaxis in dermatologic surgery: updated guidelines. Counterpoint. Dermatol Surg 2005 0.75
96 Sentinel lymph node biopsy for melanoma: one procedure but many questions: comment on "Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma". Arch Dermatol 2011 0.75
97 Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure. Ophthalmology 2008 0.75
98 Discordance in histopathologic evaluation of melanoma sentinel lymph node biopsy with clinical follow-up: results from a prospectively collected database. Ann Surg Oncol 2014 0.75
99 The Z-plasty transposition flap for reconstruction of the middle cheek. J Am Acad Dermatol 2002 0.75
100 Verrucous plaques on the leg. Arch Dermatol 2003 0.75
101 Association of nevus count with prevention attitudes and behaviors before melanoma diagnosis. Melanoma Res 2016 0.75
102 Pediatric melanoma: an opportunity for psychosocial research. J Am Acad Dermatol 2010 0.75
103 Conventional diamond fraise vs manual spot dermabrasion with drywall sanding screen for scars from skin cancer surgery. Arch Dermatol 2002 0.75
104 In brief. Curr Probl Surg 2006 0.75
105 Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation. JCI Insight 2017 0.75
106 The effects of a professionally produced videotape on education and anxiety/distress levels for patients with newly diagnosed melanoma: a randomized, prospective clinical trial. J Am Acad Dermatol 2005 0.75